Comparison of the Efficacy of Conventional Landmark, Ultrasound-Assisted, and Real-Time Ultrasound-Guided Techniques in Spinal Anesthesia for Obese Patients
Launched by ULUDAG UNIVERSITY · Dec 20, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different methods of giving spinal anesthesia to obese patients who need orthopedic surgery on their lower limbs. Spinal anesthesia is a way to numb the lower part of the body, and this trial will compare three techniques: the traditional method that relies on anatomical landmarks, a method that uses ultrasound to assist, and a real-time ultrasound-guided method. The main goal is to see which technique is most successful on the first attempt in obese patients.
To be eligible for this trial, participants need to be at least 18 years old and have a body mass index (BMI) of 30 or higher. They should be scheduled for lower extremity orthopedic surgery and fall into certain health categories (ASA I-III). Patients with severe health issues, known allergies to local anesthetics, or other conditions that would prevent safe spinal anesthesia are not eligible. If you decide to participate, you can expect a thorough evaluation and potentially better outcomes from the anesthesia technique used during your surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older
- • Patients who will undergo lower extremity orthopedic surgery
- • ASA I-II-III patients
- • BMI 30 kg/m² and above
- Exclusion Criteria:
- • BMI \< 30 kg/m²
- • ASA IV-V patients
- • Severe cardiovascular disease
- • Patients with a known or suspected allergy to local anesthetics
- • Contraindications of spinal anesthesia (eg, coagulopathy, puncture site infection)
About Uludag University
Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported